Verve Therapeutics
VERV
$6.16
Share price
-0.96%
Change (1 day)
-61.04%
Change (1 year)
Verve Therapeutics (VERV) - P/B ratio
P/B ratio as of April 2024 : 0.8599
According to Verve Therapeutics's latest financial reports the company has a price-to-book ratio of 0.8599.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Verve Therapeutics - P/B ratio (from 2021 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 1.87 | -13.57% |
| 2022-12-31 | 2.16 | -56.47% |
| 2021-12-31 | 4.97 | |
| 2020-12-31 | N/A |